Valuation Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE 16:00:02 2026-09-25 EDT			5-day change	1st Jan Change
292.84 ^USD	-0.54%		+5.32%	+46.80%

09-25	Charles River Laboratories's DAS Segment Faces Largest Margin Upside, RBC Says	MT
09-25	Deutsche Bank Raises Price Target on Charles River Laboratories International to $320 From $300, Keeps Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,941	11,138	12,252	9,520	10,023	13,980	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	39.47%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	16,092	15,613	15,219
Change	-	-36.28%	7.39%	-20.91%	3.29%	34.71%	-2.98%	-2.52%
P/E	49.4x	23.1x	25.9x	931x	-70x	77.8x	31.3x	27.9x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	4.64x	3.95x	3.51x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0x	2.3x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	3.57x	3.49x	3.31x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	4.11x	3.9x	3.6x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	15.7x	14x	12.8x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	19.6x	17.1x	15.1x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	50.6x	25.4x	32x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	1.98%	3.93%	3.12%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	3.763	9.362	10.5
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,918	4,003	4,224
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	1,023	1,111	1,187
EBIT ¹	742.1	834	838.8	805.9	793.9	821.5	915.6	1,008
Net income ¹	391	486.2	474.6	10.3	-144.3	164.1	431.1	475.7
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	2,112	1,633	1,239
Reference price ²	375.34	218.92	238.84	186.16	203.66	292.84	292.84	292.84
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	47,739	-	-
Announcement Date	2/16/22	2/22/23	2/14/24	2/19/25	2/18/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	77.82x	4.11x	15.72x	-.--%	13.98B
LONZA GROUP AG	33.26x	5.97x	17.88x	0.98%	47.97B
IQVIA HOLDINGS INC.	34.82x	3.35x	14.46x	-.--%	44.5B
REVOLUTION MEDICINES, INC.	-21.07x	227.64x	-22.77x	-.--%	43.93B
BEONE MEDICINES AG	47.27x	5.47x	29.96x	-.--%	41.03B
CELLTRION, INC.	26.85x	7.74x	19.93x	0.42%	29.85B
MEDPACE HOLDINGS, INC.	35.19x	5.78x	26.24x	-.--%	17.27B
TEMPUS AI, INC.	-61.04x	9.99x	243.78x	-.--%	15.34B
EUROFINS SCIENTIFIC SE	25.79x	2.21x	9.6x	1.04%	15.3B
Average	22.10x	30.25x	39.42x	0.27%	29.91B
Weighted average by Cap.	22.72x	41.74x	25.57x	0.28%